Bioventix PLC (BVXP)

Industry Biotechnology


This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

1,550.00p

Buy

1,650.00p

arrow-down-25.00p (-1.54%)

Prices updated at 02 Apr 2026, 18:28 BST
| Prices minimum 15 mins delay
|
Prices in GBX

Bioventix PLC is engaged in the field of biotechnology. Its business involves the development of high-affinity sheep monoclonal antibodies and clinical diagnostics and drugs of abuse testing.

Most recent dividend payment

0.700
Cash Dividend
09 Apr 2026
30 Mar 2026
10 Apr 2026
24 Apr 2026

Total dividend yield

Dividend history and forecast data table

YearDividend per shareDividend growth (%)
20260.7000-
20251.5000-0.01
20241.55000.16
20231.52000.19
20221.52000.20
20211.43000.20
20201.41000.20
20191.20000.18
20181.16000.22
20170.91000.21

Total dividend yield data table

Dividend yield (%)Buyback yield (%)
20269.68-
20257.87-
20244.88-
20233.53-
20223.16-
20213.09-
20202.01-
20192.21-
20181.99-
20172.06-

Dividend per share

% of earnings paid to shareholders

Dividend per share data table

YearDividend per share
20260.7000
20251.5000
20241.5500
20231.5200
20221.5200
20211.4300
20201.4100
20191.2000
20181.1600
20170.9100

% of earnings paid to shareholders data table

YearPayout ratio (%)
2026109.57
2025109.57
2024103.36
202385.92
202278.14
202174.25
202057.28
201958.87
201851.70
201748.57
Latest Financial Report as of 02 Apr 2026
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.